Associated Press | December 10, 2021
Lawrence Gostin, a public health expert at Georgetown University, doesn’t believe there’s enough scientific information on omicron to warrant companies delaying their return-to-office plans.
“There will be a constant stream of new variants as well as surges and waning of cases,” Gostin said. “We shouldn’t disrupt normal business activity at every possible trigger.”